BioCentury | Apr 14, 2014
Company News

Fresenius, Teva, Eli Lilly cancer news

...deficiency in rheumatoid arthritis patients on methotrexate . Teva, APP Pharmaceuticals Inc., Barr Pharmaceuticals Inc., Pliva d.d....
...$1.2 billion in 2013 U.S. sales of Alimta. Fresenius acquired APP in 2008, Barr acquired Pliva...
BioCentury | Apr 21, 2012
Politics & Policy

Lawmakers introduce bill for generic labeling

...branded manufacturer can change a drug's label. Last June, the U.S. Supreme Court ruled in Pliva...
BioCentury | Sep 2, 2011
Politics & Policy

Public Citizen petitions FDA on generic labeling

...label. The not-for-profit advocacy group cited a June ruling by the U.S. Supreme Court in Pliva...
BioCentury | Jun 24, 2011
Politics & Policy

Supreme Court rules for preemption on generics

...The U.S. Supreme Court ruled 5-4 on Thursday in Pliva Inc., et al. v. Mensing that...
BioCentury | Feb 8, 2010
Strategy

Medicines Co. chronicles

...APP Pharmaceuticals Inc. subsidiary of Fresenius SE (Xetra:FRE), Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) and Teva's Pliva...
BioCentury | Oct 19, 2009
Company News

Fresenius, Medicines Co., Teva cardiovascular news

...of Delaware alleging that ANDAs filed by Fresenius' APP Pharmaceuticals Inc. subsidiary, Teva and Teva's Pliva...
BioCentury | Oct 5, 2009
Company News

Hospira, Teva deal

...rights to a biosimilar version of filgrastim and a manufacturing facility in Croatia from partner Pliva...
...through its 2007 acquisition of Mayne Pharma Pty Ltd., which was co-developing the biosimilar with Pliva...
BioCentury | Sep 21, 2009
Company News

Medicines Co., Teva cardiovascular news

...The Medicines Co. said it received paragraph IV notification letters from Teva and its Pliva Hrvatska...
BioCentury | May 18, 2009
Product Development

Now the hard part

...with the intention of continuing to move the asset forward. The newco teamed up with Pliva d.d....
...initiate a 3,000-patient safety study in 2004 designed to evaluate the compound as add-on therapy. Pliva...
BioCentury | Jul 2, 2007
Clinical News

Cycloset: Phase IIIb data

...Ergo Science Corp. (see BioCentury, Oct. 25, 1999). VeroScience acquired Cycloset in May 2006 from Pliva d.d....
Items per page:
1 - 10 of 48
BioCentury | Apr 14, 2014
Company News

Fresenius, Teva, Eli Lilly cancer news

...deficiency in rheumatoid arthritis patients on methotrexate . Teva, APP Pharmaceuticals Inc., Barr Pharmaceuticals Inc., Pliva d.d....
...$1.2 billion in 2013 U.S. sales of Alimta. Fresenius acquired APP in 2008, Barr acquired Pliva...
BioCentury | Apr 21, 2012
Politics & Policy

Lawmakers introduce bill for generic labeling

...branded manufacturer can change a drug's label. Last June, the U.S. Supreme Court ruled in Pliva...
BioCentury | Sep 2, 2011
Politics & Policy

Public Citizen petitions FDA on generic labeling

...label. The not-for-profit advocacy group cited a June ruling by the U.S. Supreme Court in Pliva...
BioCentury | Jun 24, 2011
Politics & Policy

Supreme Court rules for preemption on generics

...The U.S. Supreme Court ruled 5-4 on Thursday in Pliva Inc., et al. v. Mensing that...
BioCentury | Feb 8, 2010
Strategy

Medicines Co. chronicles

...APP Pharmaceuticals Inc. subsidiary of Fresenius SE (Xetra:FRE), Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) and Teva's Pliva...
BioCentury | Oct 19, 2009
Company News

Fresenius, Medicines Co., Teva cardiovascular news

...of Delaware alleging that ANDAs filed by Fresenius' APP Pharmaceuticals Inc. subsidiary, Teva and Teva's Pliva...
BioCentury | Oct 5, 2009
Company News

Hospira, Teva deal

...rights to a biosimilar version of filgrastim and a manufacturing facility in Croatia from partner Pliva...
...through its 2007 acquisition of Mayne Pharma Pty Ltd., which was co-developing the biosimilar with Pliva...
BioCentury | Sep 21, 2009
Company News

Medicines Co., Teva cardiovascular news

...The Medicines Co. said it received paragraph IV notification letters from Teva and its Pliva Hrvatska...
BioCentury | May 18, 2009
Product Development

Now the hard part

...with the intention of continuing to move the asset forward. The newco teamed up with Pliva d.d....
...initiate a 3,000-patient safety study in 2004 designed to evaluate the compound as add-on therapy. Pliva...
BioCentury | Jul 2, 2007
Clinical News

Cycloset: Phase IIIb data

...Ergo Science Corp. (see BioCentury, Oct. 25, 1999). VeroScience acquired Cycloset in May 2006 from Pliva d.d....
Items per page:
1 - 10 of 48